Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition

2003 ◽  
Vol 39 (3) ◽  
pp. 378-387 ◽  
Author(s):  
S.J Welsh ◽  
S Hobbs ◽  
G.W Aherne
2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Meredith S. Showler ◽  
Brian P. Weiser

Abstract It is well established that thymidylate synthase inhibitors can cause cellular toxicity through uracil DNA glycosylase (UNG2)-dependent pathways. Additionally, thymidylate synthase inhibitors and HDAC inhibitors are known to act synergistically in a variety of cancer types. A recent article from J. Transl. Med. links these together by demonstrating widespread depletion of UNG2 levels across a variety of cell lines treated with HDAC inhibitors. Recent findings suggest that UNG2 depletion by HDAC inhibitors would likely be an effective method to sensitize cells to thymidylate synthase inhibitors. This is particularly important for cancer types that are typically resistant to thymidylate synthase inhibitors, such as cells that are deficient in p53 activity.


2021 ◽  
Vol 26 ◽  
pp. 100954
Author(s):  
Avani Mehta ◽  
Prateek Raj ◽  
Sandeep Sundriyal ◽  
Balasubramanian Gopal ◽  
Umesh Varshney

2007 ◽  
Vol 373 (4) ◽  
pp. 839-850 ◽  
Author(s):  
Hiromichi Kosaka ◽  
Jun Hoseki ◽  
Noriko Nakagawa ◽  
Seiki Kuramitsu ◽  
Ryoji Masui

1993 ◽  
Vol 64 (2) ◽  
pp. 157-164 ◽  
Author(s):  
Y. Furusawa ◽  
H. Maezawa ◽  
K. Suzuki ◽  
Y. Yamamoto ◽  
K. Kobayashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document